Clinical Trial Update: Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and safety data for methylphenidate hydrochloride extended-release capsules in children and adolescents with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate HCl ER Capsules (methylphenidate hydrochloride extended-release)

Snippet

Sponsor: Rhodes Pharmaceuticals, L.P. | Conditions: Attention Deficit Hyperactivity Disorder, ADHD | Phase 3 | Status: COMPLETED | Results posted: 2023-02-22